QuestionsQuestions (BFAD MEMORANDUM CIRCULAR NO. 24-B)
It aims to protect consumers and the public by ordering the confiscation of unregistered Shenyung (Growth) Balls found in the market or drug outlets, especially after Cease and Desist Orders were issued to stop their sale, distribution, and advertisements.
BFAD issued Cease and Desist Orders (CDOs) to stop the sale and distribution and to stop the product’s advertisements, to prevent unsubstantiated claims and protect the public.
They are represented as a drug, but the product is not registered with BFAD, making its claims unsubstantiated.
BFAD Food and Drug Inspectors are directed to confiscate all stocks of the product found in the market or any drug outlet.
Food and Drug Inspectors are directed to confiscate the stocks; the circular also states that assistance from police authorities may be sought for strict compliance.
The continued/unabated distribution, sale, promotions, and advertisements despite existing BFAD Cease and Desist Orders.
Because the product is represented as a drug without BFAD registration, its claims are not substantiated, and continued marketing can mislead or harm the public.
They are the earlier enforcement measures intended to stop the activity; the confiscation directive is issued only because compliance was not achieved.
Yes. It states that CDOs were also issued to stop advertisements/promotions for the protection of the public.
It implies that if the product is not registered with BFAD, its claims are not substantiated, warranting regulatory action.
Confiscate all stocks of the unregistered Shenyung (Growth) Balls that may be found in the market or the drug outlet, pursuant to the circular.
Police authorities may be sought for strict compliance; it underscores enforcement support to ensure confiscation orders are carried out effectively.
That representation as a drug (through marketing/claims) brings the product within drug regulation concerns, even if the product itself is not registered and its claims are not substantiated.
It was adopted on 29 Nov. 1989 and signed by Cecile P. Gonzalez, Director.